Integrated Wealth Concepts’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Buy |
3,445
+706
| +26% | +$230K | 0.01% | 862 |
|
|
2025
Q1 | $740K | Buy |
2,739
+227
| +9% | +$61.3K | 0.01% | 966 |
|
|
2024
Q4 | $591K | Buy |
2,512
+176
| +8% | +$41.4K | 0.01% | 1051 |
|
|
2024
Q3 | $642K | Buy |
2,336
+22
| +1% | +$6.05K | 0.01% | 980 |
|
|
2024
Q2 | $562K | Sell |
2,314
-6
| -0.3% | -$1.46K | 0.01% | 998 |
|
|
2024
Q1 | $347K | Buy |
2,320
+31
| +1% | +$4.63K | 0.01% | 1239 |
|
|
2023
Q4 | $438K | Buy |
2,289
+15
| +0.7% | +$2.87K | 0.01% | 1056 |
|
|
2023
Q3 | $403K | Buy |
2,274
+3
| +0.1% | +$531 | 0.01% | 1073 |
|
|
2023
Q2 | $431K | Sell |
2,271
-135
| -6% | -$25.6K | 0.01% | 1053 |
|
|
2023
Q1 | $482K | Buy |
+2,406
| New | +$482K | 0.01% | 864 |
|